Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas, as well as designed to inhibit the proliferation of certain malignant T-cells; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase II clinical trial for patients with either advanced or refractory renal cell cancer. Its preclinical stage products include CPI-182, an antibody designed to block inflammation and myeloid suppression; and CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a strategic collaboration with Angel Pharmaceuticals for the development its pipeline of targeted investigational medicines. The company was incorporated in 2014 and is based in Burlingame, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Corvus Pharmaceuticals Inc..
Corvus Pharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Corvus Pharmaceuticals Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Corvus Pharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Corvus Pharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Corvus Pharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of Corvus Pharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Corvus Pharmaceuticals Inc.- Key Facts
2.2 Corvus Pharmaceuticals Inc.- Geographic Locations
2.3 Corvus Pharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 Corvus Pharmaceuticals Inc.- Business Divisions
2.5 Corvus Pharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Corvus Pharmaceuticals Inc. Strategic Analysis Review
3.1 Corvus Pharmaceuticals Inc.- Key Strategies
3.2 Corvus Pharmaceuticals Inc.- Company Outlook Statement
3.3 Corvus Pharmaceuticals Inc.- SWOT Analysis
3.3.1 Corvus Pharmaceuticals Inc.- Key Strengths
3.3.2 Corvus Pharmaceuticals Inc.- Key Weaknesses
3.3.3 Corvus Pharmaceuticals Inc.- Potential Opportunities
3.3.4 Corvus Pharmaceuticals Inc.- Potential Threats
3.4 Corvus Pharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 Corvus Pharmaceuticals Inc.- Business Overview
4.2 Corvus Pharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 Corvus Pharmaceuticals Inc.- Key Products
5.2 Corvus Pharmaceuticals Inc.- Key Service Areas
5.3 Corvus Pharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 Corvus Pharmaceuticals Inc.- Company History
6.2 Corvus Pharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 Corvus Pharmaceuticals Inc.- Income Statements
7.2 Corvus Pharmaceuticals Inc.- Balance Sheet
7.3 Corvus Pharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Corvus Pharmaceuticals Inc.- Direct Competitors
8.2 Corvus Pharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 Corvus Pharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 Corvus Pharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!